within
minut
intraven
inject
lipopolysaccharid
lp
mice
platelet
accumul
larg
lung
higher
dose
lp
induc
rapid
shock
within
min
lead
death
within
h
type
shock
differ
socal
endotoxin
shock
shock
sign
death
occur
sever
hour
later
found
platelet
deplet
monoclon
antiplatelet
antibodi
prevent
lpsinduc
rapid
shock
increas
delay
lethal
japan
glycyrrhizin
gl
compound
isol
licoric
daili
slowli
infus
intraven
chronic
hepat
c
patient
singl
bolu
intraven
inject
mice
gl
mgkg
less
shortli
simultan
lp
inject
reduc
pulmonari
platelet
accumul
sever
rapid
shock
prevent
death
earli
later
period
gl
mgkg
produc
detect
abnorm
appear
activ
mice
intraperiton
inject
aspirin
dexamethason
margin
effect
lpsinduc
platelet
respons
lethal
result
suggest
platelet
play
import
role
develop
rapid
delay
type
shock
induc
lp
although
mechan
gl
suppress
platelet
respons
delay
lethal
remain
clarifi
gl
might
provid
strategi
allevi
acut
respiratori
distress
syndrom
seen
sepsi
result
may
also
support
see
front
matter
endo
intern
immunopharmacolog
wwwelseviercomlocateintimp
propos
cinatl
et
al
cinatl
j
morgenstern
b
bauer
g
chandra
p
ravenau
h
doerr
hw
glycyrrhizin
activ
compon
liquoric
root
replic
sarsassoci
coronaviru
lancet
gl
may
effect
drug
sever
acut
respiratori
syndrom
approxim
patient
develop
gramneg
sepsi
year
usa
one
quarter
develop
acut
respiratori
distress
syndrom
ard
mortal
estim
despit
current
detail
understand
patholog
sepsi
still
effect
strategi
condit
interestingli
recent
studi
suggest
inhibit
blood
coagul
benefici
addit
neutrophil
macrophag
interact
platelet
pulmonari
endotheli
cell
may
involv
ard
platelet
also
play
import
role
develop
multipl
organ
failur
sepsi
use
marker
platelet
recent
demonstr
within
minut
intraven
inject
lipopolysaccharid
lp
mice
platelet
accumul
lung
liver
particularli
lung
lower
dose
lp
platelet
soon
return
circul
higher
dose
broken
largescal
breakdown
induc
lethal
shock
respons
magnitud
depend
strain
mous
structur
lp
dose
induc
via
activ
complement
system
thu
rapid
shock
induc
lp
differ
wellknown
bendotoxin
shockq
seen
mice
latter
type
shock
sign
appear
h
later
death
occur
sever
hour
later
thought
lp
involv
mediat
sever
sign
seen
sepsi
includ
shock
variou
inflammatori
cytokin
tnf
also
involv
mediat
sign
glycyrrhizin
gl
major
constitu
aqueou
extract
obtain
root
licoric
plant
oral
administ
gl
convert
aglycon
acid
ga
gl
andor
ga
exhibit
varieti
pharmacolog
activ
includ
antiviru
activ
antihepat
activ
also
antiinflammatori
activ
via
suppress
prostaglandin
product
histamin
releas
histamin
synthesi
addit
gl
andor
ga
inhibit
complement
system
japan
gl
given
chronic
hepat
c
patient
daili
slow
intraven
infus
long
period
examin
effect
gl
ga
platelet
respons
ensu
rapid
shock
induc
mice
lp
male
balbc
mice
week
old
provid
anim
facil
univers
lp
klebsiella
strain
type
prepar
phenolwat
method
dissolv
steril
salin
mgml
inject
iv
via
tail
vein
g
bodi
weight
monoclon
antimous
platelet
antibodi
kindli
provid
dr
nagasawa
divis
hematolog
univers
tsukuba
japan
although
molecular
antigen
identifi
shown
deplet
platelet
mice
control
igg
prepar
normal
mous
serum
precipit
ammonium
sulfat
follow
dialysi
precipit
glycyron
inject
minophagen
pharmaceut
tokyo
japan
mg
ml
solut
ammonium
glycyrrhizin
equival
mgml
gl
dilut
salin
inject
intraven
iv
intraperiton
ip
g
bodi
weight
ga
tokyo
kasei
tokyo
japan
suspend
carboxymethyl
cellulos
given
stomach
syring
ml
g
bodi
weight
aspirin
sigma
st
loui
mo
usa
dissolv
salin
ad
naoh
ph
solut
adjust
hcl
dexamethason
sigma
dissolv
salin
experi
mice
move
room
temperatur
kept
h
inject
lp
rapid
platelet
respons
lp
reduc
room
temperatur
lower
unpublish
data
experi
intend
last
long
time
mice
return
normal
anim
room
h
lp
inject
procedur
compli
guidelin
care
use
laboratori
anim
tohoku
univers
two
three
drop
blood
decapit
mous
directli
collect
preweigh
test
tube
contain
ml
mm
edta
phosphatebuff
salin
ph
tube
plu
blood
weigh
volum
blood
estim
weight
blood
number
platelet
ascertain
use
cell
counter
sysmex
toa
medic
electron
kobe
japan
express
platelet
countml
blood
level
blood
lung
determin
previous
describ
briefli
collect
blood
measur
platelet
count
see
next
two
three
drop
blood
mous
collect
anoth
preweigh
tube
contain
ml
hclo
nacetylcysteinehcl
mm
reweigh
platelet
destroy
sonic
tube
cool
ice
bath
lung
rapidli
remov
kept
jar
contain
dri
ice
need
determin
level
blood
carri
soon
blood
collect
wherea
level
lung
determin
within
day
collect
separ
column
chromatographi
measur
fluorometr
previous
describ
amount
blood
lung
express
nmolg
blood
lung
sever
rapid
shock
seen
mous
within
min
lp
inject
score
describ
elsewher
score
system
sign
shock
stagger
crawl
prostrat
prostrat
weak
convuls
prostrat
strong
convuls
death
shockscor
data
express
score
individu
mice
sometim
meanfsd
appropri
estim
score
perform
blind
assist
experiment
valu
level
platelet
count
given
meanfsd
statist
signific
differ
assess
use
student
unpair
ttest
bonferroni
posthoc
test
differ
shock
score
two
experiment
group
analyz
use
ridit
rel
identifi
distribut
test
nonparametr
test
induc
almost
complet
deplet
platelet
blood
within
h
intraven
inject
fig
inject
also
fig
effect
platelet
blood
control
igg
mgkg
inject
iv
mice
blood
mous
collect
decapit
time
indic
subject
assay
platelet
count
valu
meanfsd
mice
vs
control
igg
decreas
blood
indic
blood
includ
platelet
experi
weak
sign
shock
score
appear
min
inject
control
igg
chang
platelet
count
blood
fig
mice
given
control
igg
intraven
inject
mgkg
lp
given
h
control
igg
inject
induc
sever
shock
sign
score
within
min
tabl
howev
mice
aliv
h
later
contrast
mice
given
dose
lp
induc
appar
shock
sign
within
h
lp
inject
howev
mice
die
within
h
tabl
describ
result
platelet
emphas
follow
point
describ
previous
halflif
intraven
inject
blood
although
determin
time
accur
inject
dose
nmol
per
mous
could
detect
increas
blood
inject
thu
valu
given
follow
section
amount
blood
lung
may
repres
almost
entir
present
within
platelet
shown
fig
lp
mgkg
induc
rapid
declin
platelet
blood
within
min
inject
follow
partial
recoveri
min
reciproc
chang
seen
lung
follow
chang
sever
shock
sign
seen
min
lp
inject
see
inset
tabl
fig
japan
gl
given
intraven
drip
infus
patient
hepat
thu
first
examin
effect
gl
inject
intraven
min
intraven
inject
lp
experi
gl
mgkg
significantli
reduc
chang
blood
lung
well
shock
sign
induc
mg
kg
lp
fig
gl
dose
signific
effect
either
platelet
count
blood
lung
fig
intraven
inject
mgkg
gl
min
lp
inject
mgkg
also
reduc
increas
lung
sever
shock
fig
howev
mgkg
gl
inject
intraven
earlier
timepoint
viz
min
lp
signific
effect
data
shown
intraperiton
inject
gl
mgkg
min
lp
inject
effect
either
data
shown
next
examin
effect
simultan
inject
gl
lp
lower
dose
gl
mgkg
significantli
reduc
sever
rapid
shock
induc
lp
mgkg
tend
improv
surviv
rate
h
inject
lp
tabl
shown
tabl
intraven
inject
mgkg
lp
caus
death
mice
within
h
inject
pretreat
gl
mgkg
intraven
min
lp
inject
complet
prevent
lethal
effect
lp
although
lp
still
induc
shock
score
mice
gl
lethal
mgkg
although
mgkg
produc
detect
abnorm
appear
activ
mice
fig
howev
mice
surviv
h
gl
inject
mgkg
still
aliv
h
mice
look
healthi
h
inject
gl
unlik
gl
solubl
ga
water
low
ga
use
clinic
oral
drug
therefor
test
effect
oral
administ
ga
lpsinduc
rapid
shock
fig
condit
ga
slightli
reduc
sever
shock
administ
mgkg
h
lp
inject
nonsteroid
antiinflammatori
drug
nsaid
glucocorticoid
wide
use
varieti
inflammatori
diseas
aspirin
typic
nsaid
antiplatelet
drug
dexamethason
typic
synthet
glucocorticoid
variou
murin
inflamm
model
aspirin
dexamethason
given
intraperiton
mgkg
respect
previous
report
dose
aspirin
dexamethason
effect
reduc
platelet
respons
induc
low
dose
mgkg
lp
use
present
studi
dose
lp
produc
shock
score
thu
next
experi
test
effect
drug
platelet
respons
sever
rapid
shock
induc
mgkg
lp
dose
drug
increas
return
platelet
circul
min
inject
lp
effect
although
statist
signific
larg
fig
effect
drug
shock
sign
induc
mgkg
lp
signific
fig
aspirin
dexamethason
given
combin
gl
howev
combin
tend
reduc
sever
shock
effect
gl
alon
fig
final
compar
effect
gl
aspirin
dexamethason
dose
lethal
induc
mgkg
lp
fig
although
shown
fig
effect
aspirin
dexamethason
lpsinduc
rapid
shock
margin
drug
prolong
surviv
time
mice
given
lethal
dose
lp
hand
mice
given
gl
surviv
least
h
lp
inject
result
obtain
present
experi
use
monoclon
antibodi
direct
toward
murin
platelet
suggest
platelet
critic
develop
rapid
shock
induc
lp
howev
result
suggest
may
also
play
import
role
help
anim
resist
delay
lethal
induc
lp
socal
bendotoxin
shockq
result
demonstr
gl
effect
suppress
rapid
shock
induc
lp
also
delay
bendotoxin
shockq
experiment
model
like
employ
present
studi
distinguish
rapid
delay
type
shock
lp
given
anim
singl
inject
human
patient
howev
level
endotoxin
may
increas
progress
increas
bacteri
number
patholog
gramneg
sepsi
may
also
develop
progress
therefor
two
type
shock
occur
patient
distinguish
difficult
specul
infect
gramneg
bacteria
lp
deriv
may
stimul
mechan
lead
type
shock
present
studi
direct
attent
mainli
toward
rapid
platelet
respons
lp
associ
rapid
shock
earlier
propos
lectin
pathway
form
convertas
may
involv
lpsinduc
accumul
platelet
lung
pathway
involv
subsequ
platelet
destruct
rapid
shock
interestingli
kroe
et
al
report
gl
ga
inhibit
human
complement
vitro
fujisawa
et
al
found
gl
inhibit
human
later
stage
complement
cascad
vitro
effect
seen
amolml
mgml
gl
level
gl
might
attain
blood
vivo
experi
describ
present
studi
gl
inhibit
lpsinduc
accumul
platelet
lung
addit
gltreat
mice
platelet
count
blood
return
almost
initi
level
min
lp
inject
sever
shock
markedli
reduc
result
suggest
gl
may
inhibit
earli
later
stage
lectin
pathway
although
antiinflammatori
effect
gl
might
also
involv
interestingli
gl
recent
shown
inhibit
thrombininduc
platelet
aggreg
vitro
vivo
model
thrombosi
rat
doseand
timedepend
effect
gl
vivo
thrombosi
observ
latter
studi
similar
seen
present
studi
complement
system
compos
sever
serin
proteas
upon
recognit
pathogen
mannosebind
lectin
mbl
ficolin
trigger
activ
lectin
pathway
mblassoci
serin
proteas
masp
shown
activ
lectin
pathway
involv
lpsinduc
activ
platelet
thrombinlik
activ
thrombin
also
serin
proteas
thu
like
gl
might
exhibit
inhibitori
action
lectin
pathway
inhibitori
effect
serin
proteas
also
note
mani
vivo
platelet
respons
consid
mediat
directli
indirectli
activ
complement
termin
complement
protein
suggest
gener
thrombin
event
need
clarifi
mechan
possibl
involv
antiinflammatori
effect
gl
gl
suppress
rapid
platelet
respons
lp
well
delay
lethal
induc
lp
gl
mgkg
effect
inject
intraven
shortli
lp
inject
ie
min
min
lp
suggest
effect
level
gl
present
later
time
inde
lower
dose
gl
mgkg
effect
inject
iv
simultan
lp
lower
dose
equival
mgml
blood
sinc
averag
mous
bodi
weight
g
blood
volum
ml
chronic
hepat
c
patient
gl
slowli
infus
intraven
mgkgday
long
period
would
yield
concentr
blood
mgml
compar
human
dose
murin
dose
seem
high
howev
note
pharmacokinet
profil
differ
greatli
mice
human
differ
may
partli
due
differ
heart
rate
beatsmin
human
mice
respect
thu
blood
concentr
drug
may
decreas
rapidli
mice
human
mean
larger
dose
need
former
latter
exampl
variou
murin
inflamm
model
aspirin
dexamethason
given
intraperiton
mgkg
respect
human
singl
oral
dose
drug
roughli
mgkg
respect
moreov
gl
clear
blood
within
min
intraven
bolu
inject
mice
initi
halflif
gl
blood
roughli
h
human
view
inform
vitro
concentr
given
slow
intraven
infus
gl
typic
use
human
might
expect
provid
effect
blood
concentr
suppress
prevent
platelet
respons
lp
human
patient
infect
gramneg
bacteria
result
show
gl
neither
lethal
toxic
inject
intraven
mice
mgkg
mice
surviv
h
gl
inject
mgkg
still
aliv
h
b
appar
healthi
h
inject
gl
c
display
detect
abnorm
either
appear
activ
thu
hyperton
natur
gl
solut
might
involv
least
part
rapid
death
observ
mgkg
gl
vitro
experi
ga
shown
potent
gl
although
relev
data
mice
report
rat
plasma
level
ga
agml
h
respect
either
oral
administr
intraven
inject
gl
mgkg
howev
present
studi
effect
oral
administr
ga
even
larg
dose
margin
suggest
gl
act
ga
gl
also
like
could
inject
ga
intraven
ga
might
effect
reduc
action
lp
although
nsaid
glucocorticoid
shown
protect
experiment
anim
endotoxin
shock
clinic
use
drug
controversi
present
studi
although
aspirin
dexamethason
effect
degre
promot
return
platelet
circul
suggest
reduc
degrad
platelet
lung
andor
liver
effect
margin
effect
rapid
shock
also
margin
addit
note
glucocorticoid
strongli
suppress
immun
respons
contrast
side
effect
gl
control
suggest
gl
enhanc
cellmedi
immun
enhanc
product
cytokin
interferon
incident
recent
studi
demonstr
histamin
suppress
respons
enhanc
respons
interestingli
gl
suppress
histamin
releas
histamin
synthesi
suggest
gl
may
least
part
enhanc
respons
via
suppress
histamin
releas
andor
synthesi
pulmonari
embol
common
condit
event
per
year
usa
varieti
risk
factor
platelet
import
compon
pulmonari
emboli
describ
introduct
mani
patient
develop
gramneg
sepsi
patient
high
incid
ard
intraven
inject
variou
gramposit
bacteria
also
induc
rapid
shock
shown
platelet
involv
shock
infus
streptococcu
sangui
rabbit
shown
induc
mark
accumul
platelet
lung
fungal
cell
also
induc
platelet
respons
similar
induc
lp
unpublish
data
view
find
may
help
devis
strategi
gramneg
sepsi
also
pulmonari
thromboembol
induc
varieti
risk
factor
includ
variou
infecti
diseas
earli
studi
sever
acut
respiratori
syndrom
sar
infecti
diseas
caus
new
coronaviru
reveal
thrombocytopenia
common
find
gramneg
bacteri
infect
catheterrel
sepsi
often
evid
patient
signific
percentag
develop
ard
within
week
interestingli
cinatl
et
al
recent
report
among
compound
test
includ
rivavirin
current
use
sar
gl
activ
inhibit
replic
sarsassoci
viru
vitro
although
admittedli
effect
concentr
gl
markedli
higher
drug
rivavirin
mani
toxic
effect
includ
hemolysi
drastic
reduct
hemoglobin
sinc
rapid
treatment
sar
also
sepsi
need
prevent
ard
develop
sinc
side
effect
gl
control
cinatl
et
al
propos
gl
may
effect
drug
sar
present
result
includ
find
gl
effect
suppress
socal
bendotoxin
shockq
seem
support
propos
